Navigating Diagnostics, Therapies, and MIGS for Glaucoma Patients

Be the first to review this product

Availability: In stock

$0.00
    OR

    Quick Overview

    This activity is supported by educational grants from Alcon Laboratories Inc., Allergan Inc., Bausch + Lomb, and Glaukos Corporation.
    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.
    Activity Expiration DateAugust 31, 2018

    Navigating Diagnostics, Therapies, and MIGS for Glaucoma Patients

    Double click on above image to view full picture

    Zoom Out
    Zoom In

    More Views

    Details

    This activity is supported by educational grants from Alcon Laboratories Inc., Allergan Inc., Bausch + Lomb, and Glaukos Corporation.

    Credits: By completing this activity you will earn 1.0 AMA PRA Category 1 Credit™.

    Activity Expiration DateAugust 31, 2018

    Course Objectives
    Upon successful completion of this activity, participants should be able to:
    - Identify the diagnostic protocols necessary to evaluate fluid drainage and optic nerve structure and function to guide glaucoma therapy decisions
    - Analyze the risks and benefits of combination therapy
    Describe how and when to integrate new MIGS options from early to advanced glaucoma

    Product Tags

    Use spaces to separate tags. Use single quotes (') for phrases.